(Q46198423)

20 December 2017

title

A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration (English)

1 reference

20 December 2017

0 references

6

1 reference

20 December 2017

author name string

Costanza Burattini

1

1 reference

20 December 2017

Andrew J McGeehan

2

1 reference

20 December 2017

William C Griffin

3

1 reference

20 December 2017

Justin T Gass

4

1 reference

20 December 2017

Jennifer R Kinder

5

1 reference

20 December 2017

M Foster Olive

7

1 reference

20 December 2017

publication date

1 March 2008

1 reference

20 December 2017

published in

Addiction Biology

1 reference

20 December 2017

volume

13

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

70-79

1 reference

20 December 2017

Acamprosate inhibits Ca2+ influx mediated by NMDA receptors and voltage-sensitive Ca2+ channels in cultured rat mesencephalic neurones.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Alteration of ethanol self-administration by naltrexone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Ethanol-reinforced behaviour in the rat: effects of naltrexone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Synthesis and assessment of [11C]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Effects of acamprosate on ethanol-seeking and self-administration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Naltrexone persistently reduces rats' intake of a palatable alcoholic beverage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

The neurobiology of addiction: implications for voluntary control of behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Disposition of narcotics and narcotic antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

The neural basis of addiction: a pathology of motivation and choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Effect of the combination of naltrexone and acamprosate on alcohol intake in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Anatomy of CNS opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Frontal lobe changes in alcoholism: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Evaluation of the effect of stress on the blood--brain barrier: critical role of the brain perfusion time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Periodic naltrexone and propensity to take alcoholic beverage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Clinical pharmacokinetics of acamprosate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Stress-induced increase in blood-brain barrier permeability in control and monosodium glutamate-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

New pharmacological approaches for the treatment of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00097.X

10.1111/J.1369-1600.2008.00097.X

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

release_ixewxeggt5ekxmd5mobdfrf7pa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ixewxeggt5ekxmd5mobdfrf7pa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

20 December 2017